Nanotemper technologies establishes advisory board to propel innovation and growth
Munich, Germany — July 12, 2024
The members of the newly formed advisory board
NanoTemper Technologies is proud to announce a significant milestone in its journey toward excellence and innovation in the biotech industry. The company has established an advisory board consisting of five distinguished professionals, each a seasoned expert in their respective fields. This move underscores NanoTemper Technologies’ commitment to fostering cutting-edge development while staying true to its mission – to create a world where every disease is treatable.
Bettina Berendsen
Senior Associate Advisor, e&Co. Life Sciences
Oliver Klaeffling
Managing Director, Analytik Jena
Hanns-Christian Mahler
CEO,
ten23 health
Michael Pohlscheidt
EVP & COO, Jungbunzlauer
Nikolai Ahrens
Founder,
LifeScience ORG
Philipp Baaske
Co-Founder and CEO,NanoTemper Technologies
The establishment of our advisory board marks a pivotal moment for NanoTemper Technologies
Their wealth of knowledge and experience will significantly enhance our efforts in driving innovation and maintaining the highest standards of excellence in the biotech industry. We are confident that their contributions will help us grow even stronger, uphold our principles, and directly contribute to our dynamic team.
There's more to explore
Discover more science-led content, practical guidance, and resources to deepen your knowledge and move your research forward with confidence.
The advisory board will not only provide high-level guidance but will also engage directly with NanoTemper Technologies’ teams. This collaborative approach aims to create an environment where innovation flourishes, benefiting from the direct involvement and insights of these industry leaders.Please join us in welcoming our new advisory board members. We look forward to the invaluable guidance and innovative perspectives they will bring to NanoTemper Technologies.